Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2018New England Journal of MedicineOpen Access

Mutation Clearance after Transplantation for Myelodysplastic Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

EDEric J. DuncavageWashington University in St. LouisMJMeagan A. JacobyBarnes-Jewish HospitalGCGue Su ChangJames S. McDonnell Foundation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Duncavage et al. (2018) studied this question.

synapsesocial.com/papers/69dffb672833447a7e255d36https://doi.org/10.1056/nejmoa1804714
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes2013 · 431 citations
  2. 2Molecular Minimal Residual Disease in Acute Myeloid Leukemia2018 · 802 citations
  3. 3Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes2017 · 677 citations
  4. 4Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel2017 · 376 citations
  5. 5Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation2017 · 360 citations